Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4/A
AN2 Therapeutics, Inc.
29 Mar 24
4
AN2 Therapeutics, Inc.
18 Mar 24
SC 13G
AN2 Therapeutics, Inc.
13 Feb 24
4
AN2 Therapeutics, Inc.
4 Jan 24
144
AN2 Therapeutics, Inc.
2 Jan 24
4
AN2 Therapeutics, Inc.
15 May 23
4
AN2 Therapeutics, Inc.
24 Feb 23
4
AN2 Therapeutics, Inc.
14 Nov 22
4
AN2 Therapeutics, Inc.
9 Nov 22
4
AN2 Therapeutics, Inc.
7 Nov 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | ANTX AN2 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3 | 198,000 | 594.00 k | 198,000 |
15 Mar 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 99,000 | 0.00 | 101,130 |
2 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 20.0945 | 2,777 | 55.80 k | 2,130 |
15 May 23 | ANTX AN2 Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 5.377 | 10,000 | 53.77 k | 1,015,766 |
23 Feb 23 | ANTX AN2 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.99 | 267,650 | 3.21 mm | 267,650 |